AU2872792A - A new form of liposaccharide binding protein (lbp) - Google Patents

A new form of liposaccharide binding protein (lbp)

Info

Publication number
AU2872792A
AU2872792A AU28727/92A AU2872792A AU2872792A AU 2872792 A AU2872792 A AU 2872792A AU 28727/92 A AU28727/92 A AU 28727/92A AU 2872792 A AU2872792 A AU 2872792A AU 2872792 A AU2872792 A AU 2872792A
Authority
AU
Australia
Prior art keywords
lbp
binding protein
new form
liposaccharide
liposaccharide binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU28727/92A
Inventor
Angelo M Delegeane
Jeffrey J. Seilhamer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Pharmaceuticals Inc filed Critical Incyte Pharmaceuticals Inc
Publication of AU2872792A publication Critical patent/AU2872792A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AU28727/92A 1991-09-26 1992-09-28 A new form of liposaccharide binding protein (lbp) Abandoned AU2872792A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76566091A 1991-09-26 1991-09-26
US765660 1991-09-26

Publications (1)

Publication Number Publication Date
AU2872792A true AU2872792A (en) 1993-04-27

Family

ID=25074151

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28727/92A Abandoned AU2872792A (en) 1991-09-26 1992-09-28 A new form of liposaccharide binding protein (lbp)

Country Status (4)

Country Link
EP (1) EP0605653A4 (en)
JP (1) JPH07502642A (en)
AU (1) AU2872792A (en)
WO (1) WO1993006228A1 (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6265187B1 (en) 1989-02-14 2001-07-24 Incyte Pharmaceuticals, Inc. Recombinant endotoxin-neutralizing proteins
US5420019A (en) 1993-02-02 1995-05-30 Xoma Corporation Stable bactericidal/permeability-increasing protein muteins
JP3946246B2 (en) * 1993-02-02 2007-07-18 ゾーマ・コーポレイション Pharmaceutical composition containing bactericidal / permeability improving protein (BPI) and surfactant
US5652332A (en) * 1993-03-12 1997-07-29 Xoma Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
US6214789B1 (en) 1993-03-12 2001-04-10 Xoma Corporation Treatment of mycobacterial diseases by administration of bactericidal/permeability-increasing protein products
EP0760849A1 (en) * 1993-04-30 1997-03-12 Incyte Pharmaceuticals, Inc. Recombinant bpi-based and lbp-based proteins, nucleic acid molecules encoding same, methods of producing same, and uses thereof
WO1995000641A1 (en) * 1993-06-17 1995-01-05 Xoma Corporation Lipopolysaccharide binding protein derivatives
US5770561A (en) * 1993-07-14 1998-06-23 Xoma Corporation Method for potentiating BPI protein product bactericidal activity by administration of LBP protein products
AU7330994A (en) * 1993-07-14 1995-02-13 Xoma Corporation Method for potentiating bpi protein product bactericidal activity by administration of lbp protein products
US6759203B1 (en) 1993-09-22 2004-07-06 Xoma Corporation Method for quantifying BPI in body fluids
CA2172245C (en) * 1993-09-22 2003-04-08 Jonathan Cohen Method of treating gram-negative bacterial infection by administration of bactericidal/permeability-increasing (bpi) protein
CN1133634A (en) * 1993-09-22 1996-10-16 爱克斯欧玛公司 Method for quantifying BPI in body fluids
WO1995019180A1 (en) * 1994-01-14 1995-07-20 Xoma Corporation Anti-gram-positive bacterial methods and materials
MX9602570A (en) * 1994-01-14 1997-04-30 Xoma Corp Anti-fungal methods and materials.
US5484705A (en) * 1994-01-24 1996-01-16 Xoma Corporation Method for quantifying lipopolysaccharide binding protein
US5891618A (en) * 1994-01-24 1999-04-06 Xoma Corporation Method for quantifying LBP in body fluids
US5578568A (en) 1994-04-22 1996-11-26 Xoma Corporation Method of treating conditions associated with intestinal ischemia/reperfusion
US5932544A (en) * 1994-05-31 1999-08-03 Xoma Corporation Bactericidal/permeability-increasing protein (BPI) compositions
US5932536A (en) * 1994-06-14 1999-08-03 The Rockefeller University Compositions for neutralization of lipopolysaccharides
US5646114A (en) 1994-07-11 1997-07-08 Xoma Corporation Anti-protozoan methods
US6271203B1 (en) 1994-07-07 2001-08-07 Xoma Corporation Anti-protozoan methods and materials
US5494896A (en) * 1995-03-31 1996-02-27 Xoma Corporation Method of treating conditions associated with burn injuries
JP2001520631A (en) * 1995-07-20 2001-10-30 ゾーマ コーポレイション Antifungal peptide
DK0914144T3 (en) 1996-05-10 2001-04-09 Univ Texas Therapeutic uses of BPI protein products for human meningococcemia
AU736096B2 (en) * 1996-05-23 2001-07-26 Xoma Corporation Therapeutic uses of BPI protein products in humans with hemorrhage due to trauma
US5888973A (en) * 1996-08-09 1999-03-30 Xoma Corporation Anti-chlamydial uses of BPI protein products
US6482796B2 (en) 1996-11-01 2002-11-19 Xoma Corporation Therapeutic uses of N-terminal BPI protein products in ANCA-positive patients
US6093573A (en) * 1997-06-20 2000-07-25 Xoma Three-dimensional structure of bactericidal/permeability-increasing protein (BPI)
US5990082A (en) * 1997-10-22 1999-11-23 Xoma Corporation Uses of lipopolysaccharide binding protein
US6013631A (en) * 1998-06-19 2000-01-11 Xoma Corporation Bactericidal/permeability-increasing protein (BPI) deletion analogs
US7951781B2 (en) 2006-11-02 2011-05-31 University Of Iowa Research Foundation Methods and compositions related to PLUNC surfactant polypeptides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4943527A (en) * 1985-10-04 1990-07-24 California Biotechnology Inc. Mature apoai protein production under serum free culturing conditions
US5089274A (en) * 1989-02-14 1992-02-18 Incyte Pharmaceuticals, Inc. Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat endotoxin-related disorders

Also Published As

Publication number Publication date
WO1993006228A1 (en) 1993-04-01
EP0605653A4 (en) 1995-03-15
EP0605653A1 (en) 1994-07-13
JPH07502642A (en) 1995-03-23

Similar Documents

Publication Publication Date Title
AU2872792A (en) A new form of liposaccharide binding protein (lbp)
GB9225453D0 (en) Binding proteins
AU5283793A (en) Recombinant specific binding protein
IL123872A0 (en) Isolated antibody binding to human heregulin (HRG) polypeptide
AU5132096A (en) Glubodies - multiplicities of proteins capable of binding a variety of small molecules
AU7516694A (en) Biotinylation of proteins
AU3662295A (en) Cosmetic stick
AU4382193A (en) BPI-immunoglobulin fusion proteins
AU7175694A (en) Lipopolysaccharide binding protein derivatives
AU5671994A (en) Case-bound hot-melt binding system
AU4077189A (en) Electrostatic transformer
AU4809290A (en) A camp-responsive transcriptional enhancer binding protein
AU2491288A (en) Phase modulator
AU1719792A (en) Can ends
AU671148C (en) Binding element
AU3006789A (en) Expression of hiv binding proteins
AU3449189A (en) Prosthetic finger joint
AU1180088A (en) Protein extracts
AU5740194A (en) A bone sialoprotein binding protein as well as its preparation
AU5517498A (en) Novel human gtp-binding proteins
AU2186895A (en) Polypeptides of lipopolysaccharide binding protein
AU3804589A (en) Novel proteins
EP0506377A3 (en) Calmodulin binding protein
AU1820692A (en) Novel anti-hiv antibodies
AU3096392A (en) Interface of information selling terminal